Advertisement

Topics

Genentech's juvenile idiopathic arthritis therapy wins FDA nod

05:59 EDT 14 Sep 2018 | SmartBrief

Roche Holding unit Genentech's Actemra, or tocilizumab, was granted approval by the FDA as a treatment for patients age 2 and -More

Original Article: Genentech's juvenile idiopathic arthritis therapy wins FDA nod

NEXT ARTICLE

More From BioPortfolio on "Genentech's juvenile idiopathic arthritis therapy wins FDA nod"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...